Total Payments
$779.53
2024 Payments
$232.05
Companies
15
Transactions
39
Medicare Patients
946
Medicare Billing
$137,642
Payment Breakdown by Category
Food & Beverage$779.53 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $779.53 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Exact Sciences Corporation | $138.90 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $100.33 | 1 | $0 (2022) |
| Lilly USA, LLC | $92.12 | 6 | $0 (2023) |
| Novo Nordisk Inc | $82.40 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $68.03 | 4 | $0 (2024) |
| ABBVIE INC. | $57.52 | 3 | $0 (2024) |
| PFIZER INC. | $56.39 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $37.16 | 2 | $0 (2024) |
| Amgen Inc. | $32.67 | 2 | $0 (2024) |
| Dexcom, Inc. | $23.12 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $232.05 | 12 | ABBVIE INC. ($57.52) |
| 2023 | $397.89 | 23 | Exact Sciences Corporation ($120.02) |
| 2022 | $149.59 | 4 | GlaxoSmithKline, LLC. ($100.33) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Oncology | ||||||
| 08/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.04 | General |
| 06/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Endocrinology | ||||||
| 06/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.16 | General |
| 02/07/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: CONTRACEPTIVE | ||||||
| 01/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Inflammation | ||||||
| 12/18/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.20 | General |
| 12/07/2023 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: CNS | ||||||
| 10/11/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Oncology | ||||||
| 08/15/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diabetes | ||||||
| 08/10/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Inflammation | ||||||
| 08/03/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/02/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Diabetes | ||||||
| 08/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 07/25/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/22/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/31/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Diabetes | ||||||
| 05/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Diabetes | ||||||
| 05/03/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 714 | 1,262 | $308,659 | $114,792 |
| 2022 | 7 | 232 | 277 | $66,072 | $22,850 |
Total Patients
946
Total Services
1,539
Medicare Billing
$137,642
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 172 | 487 | $182,625 | $66,170 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 250 | $62,500 | $25,889 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 86 | $15,050 | $6,150 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $11,930 | $3,455 | 29.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $6,300 | $2,840 | 45.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 39 | 54 | $6,750 | $2,492 | 36.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 17 | 19 | $2,285 | $1,594 | 69.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 12 | 23 | $2,453 | $962.03 | 39.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 19 | 21 | $3,459 | $956.92 | 27.7% |
| 98926 | Osteopathic manipulative treatment, 3-4 body regions | Office | 2023 | 18 | 26 | $2,338 | $919.34 | 39.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 16 | 19 | $1,404 | $820.30 | 58.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 54 | 68 | $2,380 | $571.20 | 24.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 28 | $1,120 | $328.71 | 29.3% |
| 17340 | Cold treatment of acne | Office | 2023 | 13 | 14 | $1,510 | $301.21 | 19.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 15 | 15 | $288.15 | $282.45 | 98.0% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2023 | 12 | 13 | $827.58 | $267.77 | 32.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 24 | $2,640 | $259.95 | 9.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $444.72 | $228.96 | 51.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 12 | $1,200 | $190.80 | 15.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 29 | 33 | $1,155 | $112.53 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 87 | $24,074 | $8,177 | 34.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 48 | $18,008 | $7,401 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 58 | $10,442 | $3,656 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $9,952 | $2,532 | 25.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 20 | $2,396 | $828.26 | 34.6% |
About Dr. Kelvin Ong, DO
Dr. Kelvin Ong, DO is a Family Medicine healthcare provider based in Tavernier, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2018. The National Provider Identifier (NPI) number assigned to this provider is 1275038283.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kelvin Ong, DO has received a total of $779.53 in payments from pharmaceutical and medical device companies, with $232.05 received in 2024. These payments were reported across 39 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($779.53).
As a Medicare-enrolled provider, Ong has provided services to 946 Medicare beneficiaries, totaling 1,539 services with total Medicare billing of $137,642. Data is available for 2 years (2022–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Tavernier, FL
- Active Since 03/30/2018
- Last Updated 01/01/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1275038283
Products in Payments
- Cologuard Collection Kit (Device) $138.90
- TRELEGY ELLIPTA (Drug) $100.33
- VRAYLAR (Drug) $57.52
- ELIQUIS (Drug) $56.39
- MOUNJARO (Drug) $55.49
- LEQVIO (Drug) $39.23
- Otezla (Drug) $32.67
- ENTRESTO (Drug) $28.80
- Dexcom G6 Transmitter (Medical Supply) $23.12
- Omnipod (Device) $20.89
- SLYND (Drug) $19.73
- Ozempic (Drug) $18.75
- Kerendia (Drug) $18.71
- Livalo (Drug) $18.71
- JARDIANCE (Drug) $18.35
- EMGALITY (Drug) $18.28
- Rybelsus (Drug) $16.53
- BREZTRI (Drug) $13.12
- Vivitrol (Drug) $12.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tavernier
Miguel Diaz, Md, MD
Family Medicine — Payments: $3,558
Family Medicine $3,558
Dr. Brian Magrane, M.d.,, M.D.,
Family Medicine — Payments: $557.75
Family Medicine $557.75
Dr. Eileen Turbessi, M.d, M.D
Family Medicine — Payments: $321.50
Family Medicine $321.50
Dr. Ramon Vargas, Md, MD
Family Medicine — Payments: $107.48
Family Medicine $107.48
Dr. Emasenyie Isikwei, Md, MD
Family Medicine — Payments: $38.89
Family Medicine $38.89
Celso Hernandez, Md, MD
Family Medicine
Family Medicine